Hara Tetsuro, Araake Minako, Watabe Hiroomi
Jpn J Antibiot. 2002 Dec;55(6):844-54.
In vitro antibacterial activity of fosfomycin was evaluated by various methods. Strains of methicillin-sensitive Staphylococcus aureus, methicillin-sensitive coagulase-negative Staphylococci and Escherichia coli were much more susceptible when glucose-6-phosphate was added to the test medium, but strains of Serratia marcescens and Pseudomonas aeruginosa were not affected. Nutrient agar instead of Mueller-Hinton agar allowed to exhibiting the higher activity of fosfomycin against all the species tested. The activity of fosfomycin was as equivalent or superior to those of cefazolin, cefmetazole, cefotiam and piperacillin. The susceptibility of strains isolated during 2000 to 2001 to fosfomycin was almost the same as that of the isolates reported in 1975. Fosfomycin was considered to show high efficacy in several infections, since it has maintained its favorable antibacterial activities against several bacterial species for more than 20 years after the first application to clinical practice.
通过多种方法评估了磷霉素的体外抗菌活性。当向测试培养基中添加6-磷酸葡萄糖时,甲氧西林敏感金黄色葡萄球菌、甲氧西林敏感凝固酶阴性葡萄球菌和大肠杆菌菌株的敏感性更高,但粘质沙雷氏菌和铜绿假单胞菌菌株不受影响。用营养琼脂代替穆勒-欣顿琼脂可使磷霉素对所有测试菌种表现出更高的活性。磷霉素的活性与头孢唑林、头孢美唑、头孢替安和哌拉西林相当或更高。2000年至2001年分离的菌株对磷霉素的敏感性与1975年报道的分离株几乎相同。磷霉素在首次应用于临床实践20多年后,仍对多种细菌保持良好的抗菌活性,因此被认为在几种感染中显示出高效。